Capital World Investors
LOXO

Capital World Investors’s Loxo Oncology, Inc LOXO Stock Holding History

Capital World Investors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-262,000
Closed -$6.86M – 511
2016
Q3 		$6.86M Hold
262,000
– – ﹤0.01% 464
2016
Q2 		$6.07M Hold
262,000
– – ﹤0.01% 470
2016
Q1 		$7.16M Buy
+262,000
New +$5.48M ﹤0.01% 461

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors's LOXO Position: Q4 2016 in Review

Capital World Investors sold out of Loxo Oncology, Inc (LOXO) in Q4 2016, closing a stake of 262,000 shares — an estimated $6.86M sold.

Capital World Investors first reported a position in LOXO in Q1 2016 and held it in 3 quarters. The position peaked at $7.16M in Q1 2016. 86 funds tracked by Wall St. Rank hold LOXO as of Q4 2016.

  • Capital World Investors reported no remaining Loxo Oncology, Inc position as of Q4 2016 after selling out during the quarter.
  • Capital World Investors sold 262,000 Loxo Oncology, Inc shares in Q4 2016, an estimated $6.86M.
  • Capital World Investors first reported a position in Loxo Oncology, Inc in Q1 2016 and held it in 3 quarters.
  • Capital World Investors's Loxo Oncology, Inc position peaked at $7.16M in Q1 2016.
  • 86 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2016.

Based on Capital World Investors's 13F filing for Q4 2016, filed 15 Feb 2017.